Grace Therapeutics GRCE
NASDAQ GRCE
$1.97 -0.01 (-0.51%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Non-cash Items (2019 - 2020)

Updated

Grace Therapeutics' Non-cash Items was -$1.99 million in fiscal Q2 2021 (quarter ended Sep 30, 2020), compared with -$4.91 million a year earlier.

Analysis

Grace Therapeutics (GRCE) Non-cash Items (2019 - 2020) Analysis & Trends

On a trailing twelve-month basis, Grace Therapeutics' Non-cash Items was -$4.22 million through Sep 30, 2020; for FY2019 (ended Mar 31, 2019), it was $8.39 million.

  • In earlier fiscal years, Non-cash Items was -$12.74 million in FY2018, -$5.54 million in FY2017 and -$5.01 million in FY2016.
  • Quarterly Non-cash Items has moved between -$7.12 million (fiscal Q1 2020) and $5.78 million (fiscal Q4 2020) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Grace Therapeutics 34.02 Mn -32.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -1.99 Mn
Jun 30, 2020 -3.11 Mn
Mar 31, 2020 5.78 Mn
Sep 30, 2019 -4.91 Mn
Jun 30, 2019 -7.12 Mn
API Access

Grace Therapeutics Non-cash Items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-cash-items&ticker=GRCE&period=max&api_key=YOUR_API_KEY